Trials / Not Yet Recruiting
Not Yet RecruitingNCT07513441
A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD)
Interventional, Open-label, Trial Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Lu AF28996 in Chinese Men and Women With Parkinson's Disease
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- H. Lundbeck A/S · Industry
- Sex
- All
- Age
- 35 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the safety of Lu AF28996, how well it is tolerated and what the body does to the drug in participants with Parkinson's disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lu AF28996 | Capsule administered orally per schedule specified in the arm description. |
Timeline
- Start date
- 2026-03-31
- Primary completion
- 2027-05-31
- Completion
- 2027-05-31
- First posted
- 2026-04-07
- Last updated
- 2026-04-07
Locations
4 sites across 1 country: China
Source: ClinicalTrials.gov record NCT07513441. Inclusion in this directory is not an endorsement.